Binding Parameters of Magnetite Nanoparticles Interaction with Anticancer Drug Doxorubicin

被引:7
|
作者
Bereznyak, Ekaterina G. [1 ]
Dukhopelnikov, Evgen V. [1 ]
Pesina, Daryna A. [1 ]
Gladkovskaya, Natalia A. [1 ]
Vakula, Arthur S. [1 ]
Kalmykova, Tatyana D. [1 ]
Tarapov, Sergey I. [1 ]
Polozov, Stanislav D. [2 ]
Krasnoselsky, Nikolay V. [2 ]
Belous, Anatoliy G. [3 ]
Solopan, Sergey A. [3 ]
机构
[1] NAS Ukraine, OYa Usikov Inst Radiophys & Elect, 12 Acad Proskury Str, UA-61085 Kharkov, Ukraine
[2] NAMS Ukraine, Grigoriev Inst Med Radiol, 82 Pushkinskaya Str, UA-61024 Kharkov, Ukraine
[3] NAS Ukraine, VI Vernadsky Inst Gen & Inorgan Chem, 32-34 Acad Palladina Ave, UA-03680 Kiev, Ukraine
关键词
Magnetite nanoparticles; Doxorubicin; Binding parameters; VIS spectroscopy; Ferromagnetic resonance; FE3O4; NANOPARTICLES; DELIVERY; ANTHRACYCLINES; SURFACE; AGENTS; TUMOR;
D O I
10.1007/s12668-019-00614-2
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Magnetic nanoparticles have received great interest for their use in cancer diagnostics and therapy. They can be loaded with the chemotherapeutic agents and used for the targeted delivery to the tumor and the retention of the drugs there under the external magnetic field. In the present paper, we investigated the interaction between magnetic Fe3O4 nanoparticles, both bare and coated with trisodium citrate, and anticancer drug doxorubicin in the base and acidic forms, respectively. The changes in the drug absorption spectra in the visible region and the shift of ferromagnetic resonance spectra taking place at the drug-nanoparticle interaction were analyzed. The spectrophotometric titration data were processed using the Langmuir model of equilibrium binding. For both systems, we report the calculated thermodynamic binding parameters including the drug-nanoparticle binding constants and binding site sizes. We show that in order to interact with the doxorubicin molecules in acidic form, the surface of the nanoparticles needs to be modified with trisodium citrate which provides their surface with the negative charge. At the same time, the bare magnetite nanoparticles are able to interact with the base form of the drug. The comparison of the binding parameters in both systems has shown that the nanoparticle-citrate-doxorubicin system is more promising in terms of biomedical application.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [31] Preparation and in vitro drug delivery response of doxorubicin-loaded poly(acrylic acid)-coated magnetite nanoparticles
    Omidirad, Reyhan
    Rajabi, Farzaneh Hosseinpour
    Farahani, Bahman Vasheghani
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2013, 78 (10) : 1609 - 1616
  • [32] Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
    Pieper, Sebastian
    Onafuye, Hannah
    Mulac, Dennis
    Cinatl, Jindrich, Jr.
    Wass, Mark N.
    Michaelis, Martin
    Langer, Klaus
    BEILSTEIN JOURNAL OF NANOTECHNOLOGY, 2019, 10 : 2062 - 2072
  • [33] Doxorubicin functionalized metallic nanoparticles for anticancer and antibacterial applications
    Yesil, Irem
    Atmaca, Harika
    Degirmenci, Suna
    camli-Pulat, Cisil
    Ari, Murat
    Tepe, Muammer
    Kucuk, Ardanur
    Salmanoglu, Derya Selcen
    Sancak, Zafer
    Kilinc, Cetin
    Ilhan, Suleyman
    Yazgan, Idris
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 105
  • [34] Iron(III)-binding of the anticancer agents doxorubicin and vosaroxin
    Mjos, Katja Dralle
    Cawthray, Jacqueline F.
    Jamieson, Gene
    Fox, Judith A.
    Orvig, Chris
    DALTON TRANSACTIONS, 2015, 44 (05) : 2348 - 2358
  • [35] Doxorubicin-loaded zirconium phosphate nanoparticles for intracellular anticancer drug delivery to breast cancer cells
    Gonzalez, Millie L.
    Diaz, Agustin
    Caban, Jennifer
    Colon, Jorge
    Baez, Adriana
    CANCER RESEARCH, 2012, 72
  • [36] Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers
    Aryal, Santosh
    Grailer, Jamison J.
    Pilla, Srikanth
    Steeber, Douglas A.
    Gong, Shaoqin
    JOURNAL OF MATERIALS CHEMISTRY, 2009, 19 (42) : 7879 - 7884
  • [37] Size-transformable gelatin/nanochitosan/doxorubicin nanoparticles with sequentially triggered drug release for anticancer therapy
    Li, Kaichun
    Zhou, Dong
    Cui, Hengqing
    Mo, Guoyan
    Liu, Yu
    Zheng, Kaikai
    Zhou, Zheng
    Li, Jian
    Dai, Ping
    Sun, Jing
    Zhang, Yuhong
    Gao, Jie
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2022, 220
  • [38] Doxorubicin Immobilization on Chitosan-modified Silver Nanoparticles as a Drug Delivery Method for Effective Anticancer Treatment
    Jabar, Manar S.
    Shammaree, Shatha Abdul Wadood AL-
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (02): : 107 - 114
  • [39] Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome
    Yan, Austin
    Culp, Elizabeth
    Perry, Julie
    Lau, Jennifer T.
    MacNeil, Lesley T.
    Surette, Michael G.
    Wright, Gerard D.
    ACS INFECTIOUS DISEASES, 2018, 4 (01): : 68 - 76
  • [40] Anticancer Drug Doxorubicin Spontaneously Reacts with GTP and dGTP
    Mejia, German
    Su, Linjia
    Pandey, Popular
    Fouque, Kevin Jeanne Dit
    McGoron, Anthony J.
    Fernandez-Lima, Francisco
    He, Jin
    Mebel, Alexander M.
    Leng, Fenfei
    CHEMICAL RESEARCH IN TOXICOLOGY, 2023, 36 (04) : 660 - 668